Logo for Epoch Biodesign

Meet an Unreasonable Venture

Epoch Biodesign

Using AI-designed enzymes to enable infinite recycling of mixed plastics and textiles.

Photo of Jacob Nathan

Jacob Nathan

Founder & CEO at Epoch Biodesign

More about Jacob »
Employees 21–50
Headquarters United Kingdom
Epoch Biodesign develops enzymatic processes to recycle plastic and textile waste, starting with nylon. Using AI-driven synthetic biology and materials science, it breaks plastics down into high-purity chemical building blocks for reuse. Based in London, Epoch operates at lab scale, with a demo facility targeting 150 metric tonnes annually in 2026. Long term, it aims to license and operate its technology globally, driving scalable circularity.

Notable Achievements

  • Raised more than $50M from investors including Lowercarbon Capital, Inditex, and Extantia.
  • Working with over 30 leading brands to develop and scale circular textile solutions.
  • Built a world-class team of 30 biochemists, process engineers, and ML scientists.

Currently Operating in Ten Regions

Press Mentions

May 18, 2026

Textiles Recycling Awards 2026 Finalists Announced

Read on Middle East Africa Textile News - Kohan Textile Journal »

April 8, 2026

Lululemon backs enzymatic nylon recycling

Read on Knitting Trade Journal »

April 3, 2026

Lululemon Invests in Enzyme-Based Textile Recycling Startup Epoch Biodesign

Read on Middle East Africa Textile News - Kohan Textile Journal »

February 20, 2026

INVISTA partners with Epoch Biodesign to develop post-consumer recycled nylon 6,6

Read on Interplas Insights »

February 9, 2026

Invista and Epoch partner on enzymatic nylon recycling

Read on Knitting Trade Journal »

August 28, 2025

10 AI Applications Shaping the Future

Read on TIME.com »

Work at Epoch Biodesign

More Ventures in Energy & Environment

Get the Unreasonable Newsletter

Get monthly updates on Epoch Biodesign and all of the other ventures working to solve global challenges.

Read our Privacy Policy.